Romosozumab use and cardiovascular events

wbldb

Fusaro, Maria^1,2; Tripepi, Giovanni³

J Bone Miner Res. March 2023;38(3):452-453

Cited Works (1)

Year	Entry
2022	Miller PD, Adachi JD, Albergaria B-H, Cheung AM, Chines AA, Gielen E, Langdahl BL, Miyauchi A, Oates M, Reid IR, Santiago NR, Vanderkelen M, Wang Z, Yu Z. Efficacy and safety of romosozumab among postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease. J Bone Miner Res. August 2022;37(8):1437-1445.